Literature DB >> 13034776

Occurrence and properties of a conjugated form of Leuconostoc citrovorum factor.

V M DOCTOR, J R COUCH.   

Abstract

Keywords:  FOLIC ACID/derivatives; YEASTS

Mesh:

Substances:

Year:  1953        PMID: 13034776

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


× No keyword cloud information.
  8 in total

1.  Amount of pteroylglutamic acid and related compounds in different yeasts.

Authors:  V M DOCTOR; W H PETERSON
Journal:  Appl Microbiol       Date:  1955-01

2.  Nature of the citrovorum factor requirement of Pediococcus cerevisiae.

Authors:  R C WOOD; G H HITCHINGS
Journal:  J Bacteriol       Date:  1960-04       Impact factor: 3.490

3.  A polyglutamate form of citrovorum factor synthesized by Bacillus subtilis.

Authors:  M T HAKALA; A D WELCH
Journal:  J Bacteriol       Date:  1957-01       Impact factor: 3.490

4.  Synthesis of a substance exhibiting citrovorum factor activity by Lactobacillus arabinosus 17-5.

Authors:  V B MITBANDER; A SREENIVASAN
Journal:  Arch Mikrobiol       Date:  1954

5.  Pteroylglutamate derivatives in Pisum sativum L. Biosynthesis of cotyledonary tetrahydropteroylglutamates during germination.

Authors:  A J Roos; E A Cossins
Journal:  Biochem J       Date:  1971-11       Impact factor: 3.857

6.  FOLIC ACID DERIVATIVES SYNTHESIZED DURING GROWTH OF DIPLOCOCCUS PNEUMONIA.

Authors:  F M SIROTNAK; G J DONATI; D J HUTCHISON
Journal:  J Bacteriol       Date:  1963-03       Impact factor: 3.490

7.  Studies on the physiology of Rickettsiae. IV. Folic acids of Coxiella burnetii.

Authors:  M S MATTHEIS; M SILVERMAN; D PARETSKY
Journal:  J Bacteriol       Date:  1963-01       Impact factor: 3.490

8.  Protocol of a randomised phase III clinical trial of sequential capecitabine or 5-fluorouracil plus bevacizumab (Cape/5-FU-Bmab) to capecitabine or 5-fluorouracil plus oxaliplatin plus bevacizumab (CapeOX/mFOLFOX6-Bmab) versus combination CapeOX/mFOLFOX6-Bmab in advanced colorectal cancer: the C-cubed (C3) study.

Authors:  Takeshi Nagasaka; Hideyuki Mishima; Akira Sawaki; Mototsugu Shimokawa; Michio Inukai; Katsunori Shinozaki; Hiroaki Tanioka; Junichiro Nasu; Tomohiro Nishina; Shoichi Hazama; Masazumi Okajima; Yoshiyuki Yamaguchi
Journal:  BMJ Open       Date:  2016-06-02       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.